FDA Approves Gilead's 4-in-1 HIV Pill - Aug. 28, 2012

Having trouble viewing this email? View in Browser.

Tuesday, August 28, 2012  |   |   |   |  Pharm-Olam has offices among the most populated cities in Europe, Latin America, India, South Africa, and the USA to provide for oncology studies of all sizes. Pharm-Olam has helped bring 2 oncology compounds to NDA approval and have conducted oncology studies in over 30 countries. Our Executive VP of Clinical Development will speak at the 5th annual Oncology Clinical Trials in Emerging Regions conference in Morristown, NJ October 22-23. Sponsors can visit the Pharm-Olam website to obtain a 20% discount code. The incidence of oncology indications and standards of treatment can vary widely, so let Pharm-Olam conduct a complimentary feasibility study specific to your protocol and study budgets to use in your resource planning. Contact us at www.pharm-olam.com, info@pharm-olam.com, USA 1-713-559-7900, UK 44-0-1344 891121. •  FDA Approves Gilead Sciences, Inc. (GILD)'s 4-in-1 HIV Pill More... •  AstraZeneca PLC (AZN) Granted Marketing Authorisation in Europe for ZINFORO More... •  Novartis AG (NVS) Gets Approval From European Commission (EC) for Jakavi More... •  Lundbeck Inc. (LUN.CO) Says Cancer Drug Approved in Canada More... More Drug Approval News •  Sanofi (France) (SAN.PA) Recalls Nine Lots of Kidney Transplant Rejection Drug More... More Discontinuations News More Recalls and Warning News •  Dynavax Technologies Corporation (DVAX) Announces FDA Advisory Committee to Review HEPLISAV™ More... More BLA/NDA/ANDA News More IND News More MAA News •  Resverlogix Corporation (RVX.TO) Rises on Heart Drug Study Results More... •  Rexahn Pharmaceuticals, Inc. Reports Positive Phase 2 Data for Archexin More... •  BioSpecifics Technologies Corporation (BSTC) Announces Presentation of Additional Phase III Data from XIAFLEX® Clinical Trials for Peyronie's Disease at SMSNA/ISSM Joint Annual Meeting More... •  Repros Therapeutics Inc. (RPRX) Release: FDA Provides Recommendations for Phase 2 Protocol for Low Dose Oral Proellex® in the Treatment of Endometriosis More... •  Rexahn Pharmaceuticals, Inc. Announces Positive Top-line Phase IIa Data for Archexin in Patients With Metastatic Pancreatic Cancerr More... More Phase III News More Phase II News More Phase I News More Pre-Clinical News More Post-Approval News •  Energy Drinks Improve Heart Function, University of Siena Study More... •  Vitamin B3 May Offer New Tool in Fight Against Staph Infections, "Superbugs," Oregon State University and University of California, Los Angeles (UCLA) Study More... •  Little Evidence Supports Autism Treatment Options in Adolescents, Vanderbilt University Study More... •  Link Between Protein and Aggressive, Recurring Prostate Cancer Discovered, Johns Hopkins University Study More... •  New Study in The Journal of Maternal-Fetal and Neonatal Medicine Shows Fetal Cell-Free DNA in Maternal Blood Unaffected by Trisomy Risk More... More General Clinical Research News Design and Development of Antibodies to Complex Protein Targets for Critical Assay Applications October 3, 2012 Online Webinar: Webinar Begins at 1pm EST. Examination of functional and therapeutic antibody-antigen x-ray crystal structures provides critical insight into B-cell epitope architecture. SDIX Genomic Antibody Technology™ is designed for development of antibodies that recognize conformational epitopes in critical assay formats such as sandwich immunoassays and flow cytometry and, enables targeting of antibodies to specific sites of native proteins. Antigen and antibody design strategies useful for different assay formats and classes of protein targets, including secreted and multipass membrane proteins are discussed. For more information please visit http://www.sdix.com/learn. • Pharm Country (Summit, New Jersey) Celgene Lead Clinical Research Scientist Provide leadership and direction to the assigned Clinical Research Scientists. Review work and project responsibilities within the group and assign task to ensure equitable distribution of responsibilities as well as leadership and development opportunities. • Biotech Beach (Irvine, California) Lab Support, A Division Of On Assignment Clinical Lab Scientist Perform diagnostic laboratory activities on the basis of standard operating procedures. Contribute to writing and adjusting of Standard Operating Procedures (SOP's). Consults with the Senior CLS regarding the daily work flow of the clinical laboratory and troubleshooting. • Genetown (Cambridge, Massachusetts) Vertex Clinical Process Associate Responsible for managing the lifecycle of relevant policies, SOPs, work instructions and business documents by serving as a workflow coordinator for the functions he/she supports. The Associate is also responsible for managing the execution of the development and revision of process documents by training authors on document standards, criteria and adherence to timelines. • BioMidwest (Northbrook, Illinois) Astellas Pharma US Clinical Study Manager Plan, initiate and execute assigned clinical studies with operational excellence. Be accountable for effective management of budgets, timelines and resources for assigned clinical studies and implementation of appropriate standards and processes to ensure clinical study quality. • Biotech Bay (South San Francisco) KaloBios Pharmaceuticals, Inc. Senior Clinical Research Associate Will be a key contributor to KaloBios' clinical development programs as a lead CRA for our respiratory program, and the hands-on management of an early-phase oncology clinical study. This person will work closely with the Study Manager, Director Clinical Research Operations, and the Chief Medical Officer in assisting with study startup and management in partnership with CROs. • Get Noticed! Add your resume to the BioSpace Career Center! • See more than 5,000 job postings in the BioSpace Career Center! 2012 Pharm Country Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the tri-state area. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Pharm Country Career Fair, Bridgewater, NJ September 13, 2012 • Biotech Beach Career Fair, San Diego, CA September 20, 2012 • Biotech Bay Career Fair, Burlingame, CA October 3, 2012 • BioCapital Career Fair, Bethesda, MD October 9, 2012 • BioMidwest Career Fair, Lincolnshire, IL October 22, 2012 • Bio NC Career Fair, Durham, NC October 25, 2012 • Genetown Career Fair, Cambridge, MA November 5, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience •  U.S. Patent Granted for Verona Pharma's RPL554 More... •  China Botanic Receives New Patent on Its Comprehensive Method to Enhance the Medicinal Value of Schisandra More... More Patent News New Emerging R&D and Clinical Trial Locations • Compare 5 new emerging R&D locations in terms of population, economic activity, healthcare infrastructure, and current R&D activity. • Analyze how clinical trial numbers are changing in China, India, and Eastern Europe. • Develop strategies for geographic outsourcing. Click Here for More Information. Hot Company NITTO DENKO Avecia Inc. 125 Fortune Boulevard Milford, Massachusetts 01757 U.S.A. Phone: 508-532-2500 Fax: 508-532-2503 Avecia, a recognized leader in the development and manufacture of DNA and RNA therapeutics, offers customized solutions and proven expertise that can seamlessly support your oligonucleotide product from small scale modeling to commercial launch. As a part of the Nitto Denko Corporation, Avecia's commitment to the future is driven by innovative ideas and flexible solutions, designed to provide our customers with the best in service, quality, and technology. More Company Profiles Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship ClinicaSpace 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 ClinicaSpace 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the ClinicaSpace News Beat Team. Editor & Publisher: Lana Ho Editorial & Production Staff: Maysa Darwish, Tammy Liu ClinicaSpace.com - Clinical Trials. Clinical Research. Community. • ClinicaSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 ClinicaSpace http://www.clinicaspace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.